Virbac - Centrovet

What Virbac - Centrovet does

Virbac - Centrovet (commercial name Virbac Chile) is the Chilean operating subsidiary of the France-headquartered Virbac Group, a global animal health company listed on Euronext Paris (EPA: VIRP). The company develops and distributes veterinary pharmaceuticals, vaccines, nutritional products, and diagnostic kits for six species categories: companion animals (dogs and cats), cattle, poultry and swine, aquaculture (salmonids and other fish), and specialty species (bees, goats, sheep, rabbits). Its product portfolio spans the major therapeutic classes relevant to animal health — antibiotics, antiparasitics, vaccines, anti-inflammatories and analgesics, hormones, anesthetics, dermatology and oral hygiene products, nutritional supplements, and diagnostic kits — with branded sub-lines including Veterinary HPM (pet nutrition), AQUADENT FR3SH (oral care), FELIGEN CRP/R (feline vaccine), and MOVOFLEX (joint support).

The business operates on a B2B2C model: products are sold primarily through veterinary clinics and animal health professionals, reaching pet owners and livestock producers indirectly, and through agricultural and aquaculture supply chains serving commercial farms. Marketing is driven through the corporate website (cl.virbac.com) with species-specific educational content, plus organic presence on YouTube, Instagram, and Facebook; an online bill-payment portal supplements the traditional channel mix. Pricing is not publicly disclosed.

As a wholly-owned subsidiary, Virbac Chile has no independent funding history, no publicly disclosed headcount, and no disclosed revenue. The strategic agenda in the near term is led by the 2024-appointed Gerente General, Andrés Engelbreit, with the company positioning itself as a comprehensive, multi-species animal health provider in Chile — a market where aquaculture (notably salmon farming) and the livestock sector provide differentiated exposure relative to pure-play companion-animal competitors.

Name

Virbac - Centrovet

Legal name

Virbac

Website

https://centrovet.com

Company type

Private

Founded year

2009

Operating status

Operating

Short description

Virbac - Centrovet (Virbac Chile) is the Chilean subsidiary of global animal health group Virbac, distributing veterinary pharmaceuticals, vaccines, nutrition, and diagnostics for companion animals, livestock, and aquaculture across Chile.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Animal Food Manufacturing (3111), Other Animal Food Manufacturing (311119)

SIC

Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)

akta.pro primary industry

Veterinary Vaccines (Biologics) (HLAMAEAL)

akta.pro secondary industries

Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Antimicrobials & Anti-infectives (HLAMAEAE), Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals) (HLAMAEAN), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Veterinary vaccines
• Aquaculture health solutions
• Pet nutrition supplements

Headquarters

HQ city

Santiago

HQ country

Chile

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales

Distribution channels3 records

Marketing channels3 records

Core offering

Virbac Chile develops, distributes, and markets veterinary pharmaceuticals, vaccines, and nutritional products for companion animals (dogs, cats), livestock (cattle, poultry, swine), and aquaculture species. The portfolio spans antibiotics, antiparasitics, anti-inflammatories, hormones, dermatology, dental hygiene, anesthetics, and diagnostic kits distributed primarily through veterinary clinics and agricultural supply chains in Chile.

Differentiator

Problem solved

Functional benefit

Brands

• Veterinary HPM: A specialized nutrition product line for pets mentioned on the website.
• AQUADENT FR3SH
• FELIGEN CRP/R
• MOVOFLEX

Products and services

• Veterinary HPM

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves4 records

Expansion highlights4 records

Direct peers

• Vetoquinol: Independent French veterinary pharmaceutical company focused on companion animals and livestock. Comparable in size to Virbac Group and competes in overlapping product categories including dermatology, anti-infectives, and parasiticides.
• Ceva Santé Animale: France-based global animal health company similar in size and focus to Virbac. Competes in veterinary biologicals (vaccines), pharmaceuticals, and has meaningful aquaculture exposure — directly comparable in scope and scale to Virbac Chile.
• Dechra Pharmaceuticals: Specialty veterinary pharmaceutical company acquired by EQT — focused on companion animal endocrinology, dermatology, and ophthalmology. Comparable specialty pharma positioning in the higher-value segments of the portfolio Virbac Chile sells.
• Benchmark Holdings: UK-based aquaculture health and genetics specialist with significant salmon vaccine and pharmaceutical operations. Highly comparable on the aquaculture vertical that is a strategic focus for Virbac Chile, particularly around Chilean salmon farming.
• Zoetis: The world's largest animal health company with a multi-species portfolio across companion animals, livestock, and aquaculture (including salmon vaccines via Pharmaq). Directly competes with Virbac Chile across every species category the company serves in Chile.
• Phibro Animal Health: Animal health and nutrition company with strong livestock and aquaculture exposure including vaccines, parasiticides, and nutritional specialties. Closely comparable on the production-animal and aquaculture side of Virbac Chile's business.
• Merck Animal Health (MSD Animal Health): Global animal health division of Merck/MSD with broad companion animal, livestock, and aquaculture portfolios. Competitor for vaccines, parasiticides, and pharmaceuticals across Virbac Chile's served species.
• Elanco Animal Health: Major global animal health company formed via spin-off and subsequent acquisition of Bayer Animal Health. Directly competes across companion animal pharma, livestock, and aquaculture product lines in Latin America.
• Boehringer Ingelheim Animal Health: Top-3 global animal health player with significant vaccine, parasiticide, and pharmaceutical franchises across companion and production animals. Competes head-to-head with Virbac Chile across species.

Broad incumbents

• IDEXX Laboratories: Global leader in veterinary diagnostics (kits, instruments, reference lab services). Overlaps with Virbac Chile's diagnostic kits category and serves the same veterinary professional channel, but is a much larger, publicly-traded incumbent focused almost entirely on diagnostics.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC5PTp64KPyD652m0wAm5bfA
• Facebookfacebook.com/VirbacChile
• Instagraminstagram.com/virbac_Chile
• LinkedInlinkedin.com/company/centrovet

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Virbac - Centrovet